271 related articles for article (PubMed ID: 29509288)
21. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
[TBL] [Abstract][Full Text] [Related]
23. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
[TBL] [Abstract][Full Text] [Related]
24. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.
Zhao Y; Shen XF; Cao K; Ding J; Kang X; Guan WX; Ding YT; Liu BR; Du JF
Front Immunol; 2018; 9():282. PubMed ID: 29497426
[TBL] [Abstract][Full Text] [Related]
26. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
27. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
28. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
Garg A; Spector SA
J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
[TBL] [Abstract][Full Text] [Related]
29. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
30. Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL.
Ferrer G; Jung B; Chiu PY; Aslam R; Palacios F; Mazzarello AN; Vergani S; Bagnara D; Chen SS; Yancopoulos S; Xochelli A; Yan XJ; Burger JA; Barrientos JC; Kolitz JE; Allen SL; Stamatopoulos K; Rai KR; Sherry B; Chiorazzi N
Leukemia; 2021 Nov; 35(11):3163-3175. PubMed ID: 33935280
[TBL] [Abstract][Full Text] [Related]
31. CD1d is a novel cell-surface marker for human monocytic myeloid-derived suppressor cells with T cell suppression activity in peripheral blood after allogeneic hematopoietic stem cell transplantation.
An B; Lim JY; Jeong S; Shin DM; Choi EY; Min CK; Hong SH
Biochem Biophys Res Commun; 2018 Jan; 495(1):519-525. PubMed ID: 29108995
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive role of CD11b
Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
[TBL] [Abstract][Full Text] [Related]
33. Endoplasmic reticulum stress induced LOX-1
Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
35. CHBP induces stronger immunosuppressive CD127
Li J; Tu G; Zhang W; Zhang Y; Zhang X; Qiu Y; Wang J; Sun T; Zhu T; Yang C; Rong R
Cell Death Dis; 2021 Feb; 12(2):177. PubMed ID: 33579907
[TBL] [Abstract][Full Text] [Related]
36. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease.
Park MY; Lim BG; Kim SY; Sohn HJ; Kim S; Kim TG
Front Immunol; 2019; 10():183. PubMed ID: 30863394
[TBL] [Abstract][Full Text] [Related]
37. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
[TBL] [Abstract][Full Text] [Related]
38. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
Front Immunol; 2021; 12():676679. PubMed ID: 34149712
[TBL] [Abstract][Full Text] [Related]
39. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection.
Meng F; Chen S; Guo X; Chen Z; Huang X; Lai Y; Lin M
Inflammation; 2014 Oct; 37(5):1799-805. PubMed ID: 24788988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
